Pancreatic cancer: Emerging field of regulatory B-cell-targeted immunotherapies

Overview of attention for article published in Frontiers in immunology, March 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 15 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 33,669 followers.

RT @FrontImmunol: New Research: Pancreatic cancer: Emerging field of regulatory B-cell-targeted immunotherapies: Pancreatic ductal adenocar…

24 Mar 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: Pancreatic cancer: Emerging field of regulatory B-cell-targeted immunotherapies: Pancreatic ductal adenocar…

24 Mar 2023

Reply Repost Favourite

New Research: Pancreatic cancer: Emerging field of regulatory B-cell-targeted immunotherapies: Pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, is characterized by a high mortality rate and poor prognosis.… https://t.co/V

23 Mar 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.